| Pharmaceutical active ingredients: |
| Ixabepilone |
| Available forms, composition and doses of Ixempra: |
| Injectable; Injection; Ixabepilone 15 mgInjectable; Injection; Ixabepilone 45 mg |
| Ixempra medical category: |
| Human:Anticancer drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DC04 - Ixabepilone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbBaxterDKSH |
| Related documents and information about Ixempra: |
| Ixempra prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ixacor | Ezetimibe | Roemmers Laboratorios |
| Ixana Lozenges | Ambay; Hexylresorcinol Sodium Benzoate; Senega | Quimica Medical Argentina |
| Ixana Syrup | Aescin; Ambay; Guaifenesin; Senega; Sodium Benzoate | Quimica Medical Argentina |
| Ixazotrim | Sulfamethoxazole; Trimethoprim | Cantabria |
| Ixel | Milnacipran Hydrochloride | Pierre Fabre; Algol Pharma; Janssen; Medibrands; Orient Europharma; Roche; Silesia Laboratorios |
| Ixense | Apomorphine Hydrochloride | Takeda Pharmaceutical |
| Ixertol | Cinnarizine | Cimex Pharmazeutika |
| Ixia | Olmesartan Medoxomil | Menarini |
| Ixiaro | Japanese Encephale Virus Inactivated | Intercell |
| Ixiaro | Encephalitis Virus Strain SA14 Japanese Inactive | Novartis |